Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2022 | 01-2022 | 10-2021 | 07-2021 | 04-2021 | |
| Sales | 12,877 | 13,193 | 11,786 | 11,253 | 10,564 |
| Cost of Goods | 6,221 | 6,406 | 5,609 | 5,396 | 5,843 |
| Gross Profit | 6,656 | 6,787 | 6,177 | 5,857 | 4,721 |
| Operating Expenses | 7,188 | 6,363 | 6,523 | 6,428 | 6,211 |
| Operating Income | -311 | 830 | 263 | -175 | -647 |
| Other Income | -35 | -32 | 26 | 17 | 6 |
| Pre-tax Income | -346 | 798 | 289 | -158 | -641 |
| Income Tax | -2 | 11 | 12 | 14 | 32 |
| Net Income Continuous | -344 | 787 | 277 | -172 | -673 |
| Net Income | $-344 | $787 | $277 | $-172 | $-673 |
| EPS Basic Total Ops | -0.03 | 0.06 | 0.02 | -0.01 | -0.05 |
| EPS Basic Continuous Ops | -0.02 | 0.06 | 0.02 | -0.01 | -0.05 |
| EPS Diluted Total Ops | -0.02 | 0.05 | 0.02 | -0.01 | -0.06 |
| EPS Diluted Continuous Ops | -0.02 | 0.05 | 0.02 | -0.01 | -0.05 |
| EBITDA(a) | $257 | $1,226 | $609 | $142 | $-344 |